BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $1.88M invested in ProShares UltraShort NASDAQ Biotechnology in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$457K
2
+$450K
3
+$252K
4
UBS Group
UBS Group
Switzerland
+$11.7K

Top Sellers

1
-$111K
2
-$4.33K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$776K
2
$450K
3
$366K
4
$252K
5
$33K
6
$4K
7
$2K